3TC receives full approval.
Grodeck
B
B
Vazquez
E
E
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018450:Disease Progression; D017277:Drug Approval; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D019259:Lamivudine